Céline Mascaux - Researcher Profile

Publications

2 shown

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres , Alexander Drilon , Amélie Lusque +35 more

2019 Annals of Oncology 1292 citations

Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

Pascale Tomasini , Fabrice Barlési , Céline Mascaux +1 more

Non-small cell lung cancer (NSCLC) is still the leading cause of cancer-related death, and the treatment of advanced NSCLC relies on systemic treatments. During the last decade,...

2016 Therapeutic Advances in Medical Oncology 63 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,355
Institution: Aix-Marseille Université

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1846-2807

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.